iifl-logo

Ganga Pharmaceuticals Ltd Share Price Live

Add as a Preferred Source on Google
₹12
(0.00%)
Feb 12, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

No Chart Data Available

  • Open₹12
  • Day's High₹12
  • 52 Wk High₹14.8
  • Prev. Close₹12
  • Day's Low₹12
  • 52 Wk Low ₹9.35
  • Turnover (lac)0.96
  • P/E92.31
  • Face Value₹10
  • Book Value₹13.55
  • EPS0.13
  • Mkt. Cap (Cr.)₹7.09
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Ganga Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹12

Prev. Close

₹12

Turnover(Lac.)

₹0.96

Day's High

₹12

Day's Low

₹12

52 Week's High

₹14.8

52 Week's Low

₹9.35

Book Value

₹13.55

Face Value

₹10

Mkt Cap (₹ Cr.)

7.09

P/E

92.31

EPS

0.13

Divi. Yield

0

Ganga Pharmaceuticals Ltd Corporate Action

20 Aug 2025

12:00 AM

AGM

Announcement Date: 20 Aug, 2025

arrow

20 Aug 2025

12:00 AM

BookCloser

arrow

3 Nov 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Ganga Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Ganga Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

16 May, 2026|02:20 PM
Mar-2026Sep-2025Jul-2025Jun-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.91%

Foreign: 0.00%

Indian: 50.91%

Non-Promoter- 49.08%

Institutions: 0.00%

Non-Institutions: 49.08%

Custodian: 0.00%

Read More
Share PriceShare Price

Ganga Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

5.46

5.46

4.06

4.06

Preference Capital

0

0

0

0

Reserves

1.67

1.59

1.39

1.35

Net Worth

7.13

7.05

5.45

5.41

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

2.37

3.07

3.05

3.01

yoy growth (%)

-22.88

0.85

1.4

14.51

Raw materials

-1.23

-1.27

-1.15

-1.06

As % of sales

52.08

41.48

37.97

35.31

Employee costs

-0.42

-0.43

-0.43

-0.33

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.03

0.25

0.12

0.1

Depreciation

-0.05

-0.05

-0.05

-0.04

Tax paid

-0.01

-0.06

-0.03

-0.03

Working capital

0.35

0.27

-0.22

-0.59

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-22.88

0.85

1.4

14.51

Op profit growth

-91.96

21.96

2.83

1.79

EBIT growth

-53.42

23.04

-4.42

6.8

Net profit growth

-89.21

100.78

26.76

52.37

View Ratios
Particulars (Rupees in Crores.)Mar-2021Mar-2020

Gross Sales

2.37

3.08

Excise Duty

0

0

Net Sales

2.37

3.08

Other Operating Income

0

0

Other Income

0.25

0.17

Ganga Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,880

102.434,47,032.09705.440.865,651.2199.24

Divis Laboratories Ltd

DIVISLAB

6,761.1

71.431,83,758.685980.432,578578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,406.15

66.811,49,223.985770.142,547249.82

Cipla Ltd

CIPLA

1,431.55

31.41,16,211.65384.640.93,840.92423.39

Dr Reddys Laboratories Ltd

DRREDDY

1,336.95

33.771,08,739.11-219.40.613,802.6375.78

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Ganga Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Non Executive Dir.

SANJAY VYANKATESH KULKARNI

managing Director

BHARAT BRIJMOHAN SHARMA

E D & Wholetime Director

SRIJNA SHARMA

Independent Non Exe. Director

Aman Mukesh Chaudhari.

Independent Non Exe. Director

Munna Baijnath Chaurasia

Registered Office

Gangatat Dhanvantri Marg,

Gopcharpada Virar (E),

Maharashtra - 401305

Tel: 91-250-6098333/444

Website: http://www.ayurvedganga.com

Email: ayurvedganga@gmail.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@karvy.com

Summary

Ganga Pharmaceuticals Limited was incorporated as a Public Limited Company in Aug.94 and promoted by Brij Mohan Sharma. The Company is engaged in the business of manufacturing & trading in Pharmaceuti...
Read More

Reports by Ganga Pharmaceuticals Ltd

Company FAQs

What is the Ganga Pharmaceuticals Ltd share price today?

The Ganga Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹12 today.

What is the Market Cap of Ganga Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ganga Pharmaceuticals Ltd is ₹7.09 Cr. as of 12 Feb ‘26

What is the PE and PB ratio of Ganga Pharmaceuticals Ltd?

The PE and PB ratios of Ganga Pharmaceuticals Ltd is 92.31 and 0.89 as of 12 Feb ‘26

What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Ganga Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ganga Pharmaceuticals Ltd is ₹9.35 and ₹14.8 as of 12 Feb ‘26

What is the CAGR of Ganga Pharmaceuticals Ltd?

Ganga Pharmaceuticals Ltd's CAGR for 5 Years at 14.87%, 3 Years at -2.63%, 1 Year at -12.09%, 6 Month at -17.81%, 3 Month at 2.74% and 1 Month at 1.69%.

What is the shareholding pattern of Ganga Pharmaceuticals Ltd?

The shareholding pattern of Ganga Pharmaceuticals Ltd is as follows:
Promoters - 50.91 %
Institutions - 0.00 %
Public - 49.09 %

QUICKLINKS FOR Ganga Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.